Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States

BACKGROUND: Chlamydia trachomatis is the most common bacterial sexually transmitted infection (STI) in the United States (U.S.) [1] and remains a major public health problem. We determined the cost- benefit of screening all pregnant women aged 15–24 for Chlamydia trachomatis infection compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ditkowsky, Jared, Shah, Khushal H., Hammerschlag, Margaret R., Kohlhoff, Stephan, Smith-Norowitz, Tamar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316151/
https://www.ncbi.nlm.nih.gov/pubmed/28214469
http://dx.doi.org/10.1186/s12879-017-2248-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316151/
https://www.ncbi.nlm.nih.gov/pubmed/28214469
http://dx.doi.org/10.1186/s12879-017-2248-5

Ejemplares similares